C
Last Price
52 Week Range
MX$475.00 - MX$630.00
Next Earnings Date
May 04 2026 (Estimate)
Next Earnings Date
May 04 2026 (Est.)
Last Price
Market Cap | MX$50.17B |
EV | MX$45.94B |
Shares Outstanding | 95.74M |
Beta | 0.09 |
Industry | Medical - Pharmaceuticals |
Analyst Rating | BUY |
Analyst Target Price | |
Number of Analysts | 1 |
P/E 2026E | - |
P/Revenue 2026E | 0.33x |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Gross Margin 2026E | - |
Net Profit Margin 2026E | 3.88% |
ROE 2026E | 20.20% |
ROCE 2025 | 17.06% |
DPS 2026E | MX$18.00 |
Payout Ratio 2026E | - |
Div. Yield 2026E | 3.56% |
DPS Last 3Y CAGR |
Price
%
1M
3M
6M
1Y
3Y
5Y
C
Corporativo Fragua, S.A.B. de C.V.
FRAGUA B
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Arroyo Navarro, Javier
Employees
64,178
IPO Date
2000-01-07
Headquarters
Av. de las Americas 1254 interior UP6 P2, Col. Country Club Guadalajara, Jalisco, 44610, Mexico
The last closing price of Corporativo Fragua (FRAGUA B) is MX$505.00, reflecting a +2.23% change from the prior session. Last updated: April 1, 2026 at 5:19 PM Eastern Time
Review of Recent FRAGUA B Stock Performance trends:Past 1 Month: Corporativo Fragua (FRAGUA B) shares changed by +0.96%.Past 3 Months: The stock recorded a change of -3.85%.Past 6 Months: FRAGUA B shares posted a change of -1.13%. Last updated: March 7, 2026 at 7:37 PM Eastern Time
Over the last year, Corporativo Fragua (FRAGUA B) has established a 52-week price range between a high of MX$630.00 and a low of MX$475.00. This metric is essential for assessing the stock's annual volatility. Last updated: March 7, 2026 at 7:37 PM Eastern Time
Corporativo Fragua (FRAGUA B) is considered a low volatility stock. It has a beta of 0.09, which means it typically moves 0.09 times as much as the broader market. Over the past 52 weeks, FRAGUA B has traded within a MX$475.00 – MX$630.00 range. Last updated: March 7, 2026 at 7:37 PM Eastern Time
Based on current FRAGUA B analyst forecasts, the consensus price target for Corporativo Fragua (FRAGUA B) is MX$1415.00 for 2027. Relative to the current price of MX$505.00, this implies a positive upside of +170.04%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: April 1, 2026 at 5:19 PM Eastern Time
A MX$1,000 investment in Corporativo Fragua 5 years ago, when the stock was trading around MX$257.84, would be worth approximately MX$1958.58 today, based solely on share price performance (excluding dividends). This represents a total return of 95.86% over the period, equivalent to a compound annual growth rate (CAGR) of 14.39%. Past performance reflects historical price movements only and does not imply future results. Last updated: March 7, 2026 at 7:37 PM Eastern Time
The current Corporativo Fragua (FRAGUA B) market capitalization is approximately MX$50.17B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Corporativo Fragua's market cap fluctuates with changes in its share price and share count. Last updated: March 7, 2026 at 7:37 PM Eastern Time
In the most recently reported quarter, Corporativo Fragua (FRAGUA B) generated MX$34.02B in revenue, representing a +9.33% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: April 2, 2026 at 1:08 AM Eastern Time
In the most recently reported fiscal year, Corporativo Fragua (FRAGUA B) generated net income of MX$4.69B, compared with MX$4.90B in the prior fiscal year, representing a -4.39% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of MX$5.61B. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: April 2, 2026 at 1:08 AM Eastern Time
According to its latest quarterly filing, Corporativo Fragua (FRAGUA B) reported EBITDA of MX$2.41B, representing a -8.71% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: April 2, 2026 at 1:08 AM Eastern Time
As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.15x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: April 2, 2026 at 1:08 AM Eastern Time
Based on the latest available data, Corporativo Fragua (FRAGUA B) is currently trading at a last twelve months (LTM) P/E ratio of 11.06x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: April 2, 2026 at 1:08 AM Eastern Time
Corporativo Fragua (FRAGUA B) is currently scheduled to report its next earnings results on May 3, 2026. Earnings dates are subject to change and may be updated by the company with limited notice. Investors typically monitor upcoming earnings releases closely, as they can result in increased volatility depending on reported results, forward guidance, and management commentary. Last updated: March 7, 2026 at 7:37 PM Eastern Time
In the most recently reported quarter, Corporativo Fragua (FRAGUA B) revenue was MX$34.02B, compared with analyst consensus expectations of MX$34.29B, representing a -0.78% revenue surprise versus expectations. Earnings per share (EPS) for the quarter were MX$10.13. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: April 2, 2026 at 1:08 AM Eastern Time
Analyst assessments of whether Corporativo Fragua (FRAGUA B) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: MX$505.00Consensus price target: MX$1415.00Implied return: +170.04% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: April 2, 2026 at 1:08 AM Eastern Time
Based on the latest available analyst coverage, Corporativo Fragua (FRAGUA B) currently carries a Buy consensus rating. Analysts' average FRAGUA B price target is MX$1415.00. Relative to the current share price of MX$505.00, this suggests a potential price change of approximately +170.04%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: April 2, 2026 at 1:08 AM Eastern Time
Like other publicly traded stocks, Corporativo Fragua (FRAGUA B) shares are bought and sold on stock exchanges such as BMV and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Corporativo Fragua (FRAGUA B) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add FRAGUA B to your watchlist.
Corporativo Fragua trades under the ticker symbol FRAGUA B on the BMV stock exchange. The ticker FRAGUA B is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
As of the most recently reported period, Corporativo Fragua (FRAGUA B) employs approximately 64,178 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: March 7, 2026 at 7:37 PM Eastern Time
Corporativo Fragua (FRAGUA B) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Corporativo Fragua (FRAGUA B) stock peers based on overlapping products, services, and competitive dynamics:Raia Drogasil (RADL3)MatsukiyoCocokara (3088)Tsuruha Holdings (3391)Empreendimentos Pague Menos (PGMN3)Sugi Holdings (7649)COSMOS Pharmaceutical (3349)Sundrug (9989)Farmacias Benavides (BEVIDES B)d1000 Varejo Farma Participações (DMVF3)Dimed S.A. Distribuidora de Medicamentos (PNVL3) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Corporativo Fragua.
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers